Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | |
|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||
| Cash income from operating activities | 11.11%9.23M | 341.97%8.3M | -5.85%1.88M | -15.45%2M | 372.58%2.36M | 499.38K |
| Revenue from customers | 4.44%8.67M | 489.26%8.3M | -3.06%1.41M | 16.47%1.45M | 861.43%1.25M | --129.81K |
| Income from government grants | --553.98K | ---- | ---- | -94.69%29.05K | 358.80%547K | --119.23K |
| Other cash income from operating activities | ---- | -100.00%-1 | -8.43%469.59K | -9.23%512.85K | 125.68%565K | --250.35K |
| Cash paid | -21.66%-12.21M | -80.33%-10.03M | 3.75%-5.56M | 32.15%-5.78M | -216.35%-8.52M | -2.69M |
| Payments to suppliers for goods and services | -21.66%-12.21M | -80.33%-10.03M | 3.75%-5.56M | 32.15%-5.78M | -216.35%-8.52M | ---2.69M |
| Direct interest paid | -148.58%-168.39K | -247.24%-67.74K | 19.32%-19.51K | -34.33%-24.18K | ---18K | ---- |
| Direct interest received | 456.01%259.65K | -23.66%46.7K | 900.05%61.17K | -73.40%6.12K | 176.11%23K | --8.33K |
| Operating cash flow | -65.08%-2.89M | 51.96%-1.75M | 4.20%-3.64M | 38.21%-3.8M | -181.62%-6.15M | ---2.19M |
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | -134.39%-2.11M | -4,411.49%-899.33K | 107.67%20.86K | 86.62%-272.02K | -128.74%-2.03M | -888.77K |
| Net PPE purchase and sale | -146.11%-2.08M | -2,786.82%-845.38K | 111.98%31.46K | 86.74%-262.71K | -139.81%-1.98M | ---826.09K |
| Net intangibles purchas and sale | 9.18%-27.35K | -183.96%-30.11K | -13.85%-10.61K | 70.89%-9.32K | -19.92%-32K | ---26.69K |
| Net investment purchase and sale | ---- | ---23.84K | ---- | ---- | 44.44%-20K | ---36K |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | -134.39%-2.11M | -4,411.49%-899.33K | 107.67%20.86K | 86.62%-272.02K | -128.74%-2.03M | ---888.77K |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | 368.29%27.66M | 13.08%5.91M | 2,810.17%5.22M | -102.69%-192.7K | -29.42%7.16M | 10.14M |
| Net issuance payments of debt | 6.15%-219K | 1.28%-233.34K | -900.14%-236.36K | 81.68%-23.63K | -53.55%-129K | ---84.01K |
| Net common stock issuance | 340.73%28.03M | 12.58%6.36M | 56,402.01%5.65M | -99.86%10K | -28.73%7.29M | --10.23M |
| Net other financing activities | 64.10%-159.27K | -15.92%-443.59K | -6.85%-382.67K | ---358.13K | ---- | ---- |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | 368.29%27.66M | 13.08%5.91M | 2,810.17%5.22M | -102.69%-192.7K | -29.42%7.16M | --10.14M |
| Net cash flow | ||||||
| Beginning cash position | 71.82%7.79M | 54.56%4.53M | -59.26%2.93M | -12.49%7.2M | 610.47%8.23M | --1.16M |
| Current changes in cash | 595.84%22.66M | 103.46%3.26M | 137.51%1.6M | -315.50%-4.27M | -114.53%-1.03M | --7.07M |
| Effect of exchange rate changes | ---51.17K | ---- | ---- | ---- | ---- | ---- |
| End cash Position | 290.20%30.4M | 71.82%7.79M | 54.56%4.53M | -59.26%2.93M | -12.48%7.2M | --8.23M |
| Free cash from | -89.61%-5M | 29.17%-2.64M | 9.89%-3.72M | 49.39%-4.13M | -168.83%-8.17M | ---3.04M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |